Long-term Mortality After Stroke Among Adults Aged 18 to 50 Years

被引:186
作者
Rutten-Jacobs, Loes C. A. [1 ]
Arntz, Renate M. [1 ]
Maaijwee, Noortje A. M. [1 ]
Schoonderwaldt, Henny C. [1 ]
Dorresteijn, Lucille D. [2 ]
van Dijk, Ewoud J. [1 ]
de Leeuw, Frank-Erik [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands
[2] Med Spectrum Twente, Dept Neurol, Nijmegen, Netherlands
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2013年 / 309卷 / 11期
关键词
ISCHEMIC-STROKE; YOUNG-ADULTS; CEREBRAL INFARCTION; PROGNOSIS; CLASSIFICATION; PREDICTORS; RATIONALE; COMMUNITY; REGISTRY; EVENTS;
D O I
10.1001/jama.2013.842
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Long-term data on mortality after first-ever stroke in adults aged 18 through 50 years are scarce and usually restricted to ischemic stroke. Moreover, expected mortality not related to first-ever stroke is not taken in account. Objectives To investigate long-term mortality and cause of death after acute stroke in adults aged 18 through 50 years and to compare this with nationwide age-and sex-matched mortality rates. Design, Setting, and Participants The Follow-Up of Transient Ischemic Attack and Stroke Patients and Unelucidated Risk Factor Evaluation (FUTURE) study, a prospective cohort study of prognosis after transient ischemic attack (TIA), ischemic stroke, or hemorrhagic stroke in adults aged 18 through 50 years admitted to Radboud University Nijmegen Medical Centre, the Netherlands, between January 1, 1980, and November 1, 2010. The survival status of 959 consecutive patients with a first-ever TIA (n=262), ischemic stroke (n=606), or intracerebral hemorrhage (n=91) was assessed as of November 1, 2012. Mean follow-up duration was 11.1 (SD, 8.7) years (median, 8.3 [interquartile range, 4.0-17.4]). Observed mortality was compared with the expected mortality, derived from mortality rates in the general population with similar age, sex, and calendar-year characteristics. Main Outcome Measures Cumulative 20-year mortality among 30-day survivors of stroke. Results At the end of follow-up, 192 patients (20.0%) had died. For each stroke type, observed 20-year mortality among 30-day survivors exceeded expected mortality in the general population. [GRAPHICS] For ischemic stroke, cumulative 20-year mortality among 30-day survivors was higher in men than in women (33.7% [95% CI, 26.1%-41.3%] vs 19.8% [95% CI, 13.8%-25.9%]). The standardized mortality ratio was 4.3 (95% CI, 3.2-5.6) for women and 3.6 (95% CI, 2.8-4.6) for men. For all etiologic subtypes of ischemic stroke, observed mortality exceeded expected mortality. Conclusions and Relevance Among adults aged 18 through 50 years, 20-year mortality following acute stroke was relatively high compared with expected mortality. These findings may warrant further research evaluating secondary prevention strategies in these patients. JAMA. 2013;309(11):1136-1144 www.jama.com
引用
收藏
页码:1136 / 1144
页数:9
相关论文
共 29 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]  
AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113
[3]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[4]  
2-S
[5]  
[Anonymous], CARD DIS
[6]   HETEROZYGOSITY FOR HOMOCYSTINURIA IN PREMATURE PERIPHERAL AND CEREBRAL OCCLUSIVE ARTERIAL-DISEASE [J].
BOERS, GHJ ;
SMALS, AGH ;
TRIJBELS, FJM ;
FOWLER, B ;
BAKKEREN, JAJM ;
SCHOONDERWALDT, HC ;
KLEIJER, WJ ;
KLOPPENBORG, PWC .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) :709-715
[7]   Rationale and Design of a Randomized, Double-Blind, Parallel-Group Study of Terutroban 30 mg/day versus Aspirin 100 mg/day in Stroke Patients: The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study [J].
Bousser, M. G. ;
Amarenco, P. ;
Chamorro, A. ;
Fisher, M. ;
Ford, I. ;
Fox, K. ;
Hennerici, M. G. ;
Mattle, H. P. ;
Rothwell, P. M. .
CEREBROVASCULAR DISEASES, 2009, 27 (05) :509-518
[8]  
Breslow N.E., 1987, STAT METHODS CANC RE, VII, P82
[9]   MEASUREMENTS OF ACUTE CEREBRAL INFARCTION - A CLINICAL EXAMINATION SCALE [J].
BROTT, T ;
ADAMS, HP ;
OLINGER, CP ;
MARLER, JR ;
BARSAN, WG ;
BILLER, J ;
SPILKER, J ;
HOLLERAN, R ;
EBERLE, R ;
HERTZBERG, V ;
RORICK, M ;
MOOMAW, CJ ;
WALKER, M .
STROKE, 1989, 20 (07) :864-870
[10]   Clinical predictors of death in young and middle-aged patients with ischemic stroke or transient ischemic attack: long-term results of the Vienna Stroke Registry [J].
Greisenegger, Stefan ;
Zehetmayer, Sonja ;
Ferrari, Julia ;
Lang, Wilfried ;
Fizek, Johanna ;
Auff, Eduard ;
Lalouschek, Wolfgang ;
Serles, Wolfgang .
JOURNAL OF NEUROLOGY, 2011, 258 (06) :1105-1113